Abnormalities in the PI3K/AKT/mTOR signaling pathway are very prevalent in malignant tumors and mutations in PIK3CA have been frequently detected in many cancers including OCCC, reportedly at 40% [34]. This evidence concerns the gene AKT1 and cancer.